Transduction of human CD34+ haemopoietic progenitors of various origin using an original retrovirus vector derived from Fr-MuLV and clinically relevant procedures
Hematology and Cell Therapy · 1996
DOI: 10.1007/s00282-996-0205-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology and Cell Therapy, 1996. Verfasst von O Cohen-Haguenauer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Transfert Génétique et Oncologie Moléculaire, Institut d'Hématologie, Paris, France. Hauptthemen laut MEDLINE: Antigens, CD34, Gene Transfer Techniques, Genetic Vectors, Hematopoietic Stem Cells.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratoire Transfert Génétique et Oncologie Moléculaire, Institut d'Hématologie, Paris, France.
Zitieren
APA
Cohen-Haguenauer, O., Restrepo, L. M., Masset, M., Bayer, J., Pellerain, N., dal Cortivo, L., Marolleau, J. P., Benbunan, M., Boiron, M., & Marty, M. (1996). Transduction of human CD34+ haemopoietic progenitors of various origin using an original retrovirus vector derived from Fr-MuLV and clinically relevant procedures. Hematology and Cell Therapy. https://doi.org/10.1007/s00282-996-0205-7
Vancouver
Cohen-Haguenauer O, Restrepo LM, Masset M, Bayer J, Pellerain N, dal Cortivo L, et al. Transduction of human CD34+ haemopoietic progenitors of various origin using an original retrovirus vector derived from Fr-MuLV and clinically relevant procedures. Hematology and Cell Therapy. 1996. doi:10.1007/s00282-996-0205-7
BibTeX
@article{CohenHaguenauer1996,
author = {Cohen-Haguenauer, O and Restrepo, L M and Masset, M and Bayer, J and Pellerain, N and dal Cortivo, L and Marolleau, J P and Benbunan, M and Boiron, M and Marty, M},
title = {Transduction of human CD34+ haemopoietic progenitors of various origin using an original retrovirus vector derived from Fr-MuLV and clinically relevant procedures},
journal = {Hematology and Cell Therapy},
year = {1996},
doi = {10.1007/s00282-996-0205-7}
}
EUVIMED